Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Reist, Craig"" wg kryterium: Autor


Tytuł :
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.
Autorzy :
Goyal, Akash
Schibler, Tony
Alhanti, Brooke
Hannan, Karen L.
Granger, Christopher B.
Blazing, Michael A.
Lopes, Renato D.
Alexander, John H.
Peterson, Eric D.
Rao, Sunil V.
Green, Jennifer B.
Roe, Matthew T.
Rorick, Tyrus
Berdan, Lisa G.
Reist, Craig
Mahaffey, Kenneth W.
Harrington, Robert A.
Califf, Robert M.
Patel, Manesh R.
Hernandez, Adrian F.
Pokaż więcej
Źródło :
JAMA Network Open; 7/23/2021, Vol. 4 Issue 7, pe2117963-e2117963, 1p
Czasopismo naukowe
Tytuł :
VMJ775594_Supplementary_material – Supplemental material for Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
Autorzy :
Berger, Jeffrey S
Abramson, Beth L
Lopes, Renato D
Heizer, Gretchen
Rockhold, Frank W
Baumgartner, Iris
F Gerry R Fowkes
Held, Peter
Katona, Brian G
Norgren, Lars
W Schuyler Jones
Millegård, Marcus
Blomster, Juuso
Reist, Craig
Hiatt, William R
Manesh R Patel
Mahaffey, Kenneth W
Pokaż więcej
Temat :
110323 Surgery
Cardiology
Tytuł :
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome
Autorzy :
Becker, Richard C.
Mahaffey, Kenneth W.
Yang, Hongqiu
Marian, A. J.
Furman, Mark I.
Michael Lincoff, A.
Hazen, Stanley L.
Petersen, John L.
Reist, Craig J.
Kleiman, Neal S.
SYNERGY Investigators
Pokaż więcej
Źródło :
Journal of Thrombosis and Thrombolysis: A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science. February 2011 31(2):146-153
Czasopismo naukowe
Tytuł :
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
Autorzy :
Hiatt, William
Fowkes, F. Gerry R.
Heizer, Gretchen
Berger, Jeffrey
Baumgartner, Iris
Held, Peter
Katona, Brian
Mahaffey, Kenneth
Norgren, Lars
Jones, W. Schuyler
Blomster, Juuso
Millegård, Marcus
Reist, Craig
Patel, Manesh
Bressollette, Luc
Pokaż więcej
Temat :
[SDV]Life Sciences [q-bio]
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Źródło :
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (1), pp.32-40
Tytuł :
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Autorzy :
Hiatt, William R
Fowkes, F Gerry R
Heizer, Gretchen
Berger, Jeffrey S
Baumgartner, Iris
Held, Peter
Katona, Brian G
Mahaffey, Kenneth W
Norgren, Lars
Jones, W Schuyler
Blomster, Juuso
Millegård, Marcus
Reist, Craig
Patel, Manesh R
Pokaż więcej
Temat :
610 Medicine & health
cardiovascular diseases
Źródło :
Hiatt, William R; Fowkes, F Gerry R; Heizer, Gretchen; Berger, Jeffrey S; Baumgartner, Iris; Held, Peter; Katona, Brian G; Mahaffey, Kenneth W; Norgren, Lars; Jones, W Schuyler; Blomster, Juuso; Millegård, Marcus; Reist, Craig; Patel, Manesh R (2017). Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. New England journal of medicine NEJM, 376(1), pp. 32-40. Massachusetts Medical Society MMS 10.1056/NEJMoa1611688
Opis pliku :
application/pdf
Tytuł :
Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial
Autorzy :
Mahaffey, Kenneth W.
Yang, Qinghong
Pieper, Karen S.
Antman, Elliott M.
White, Harvey D.
Goodman, Shaun G.
Cohen, Marc
Kleiman, Neal S.
Langer, Anatoly
Aylward, Philip E.
Col, Jacques J.
Reist, Craig
Ferguson, James J.
Califf, Robert M.
SYNERGY Trial Investigators
Pokaż więcej
Źródło :
Journal of General Internal Medicine. March 2008 23(3):310-316
Czasopismo naukowe
Tytuł :
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Autorzy :
Berger, Jeffrey S.
Katona, Brian G.
Jones, W. Schuyler
Patel, Manesh R.
Norgren, Lars
Baumgartner, Iris
Blomster, Juuso
Mahaffey, Kenneth W.
Held, Peter
Millegård, Marcus
Heizer, Gretchen
Reist, Craig
Fowkes, F. Gerry
Hiatt, William R.
Pokaż więcej
Temat :
610 Medicine & health
Cardiology and Cardiovascular Medicine
cardiovascular diseases
Źródło :
Berger, Jeffrey S; Katona, Brian G; Jones, W Schuyler; Patel, Manesh R; Norgren, Lars; Baumgartner, Iris; Blomster, Juuso; Mahaffey, Kenneth W; Held, Peter; Millegård, Marcus; Heizer, Gretchen; Reist, Craig; Fowkes, F Gerry; Hiatt, William R (2016). Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. American Heart Journal, 175, pp. 86-93. Elsevier 10.1016/j.ahj.2016.01.018
Opis pliku :
application/pdf
Tytuł :
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
Autorzy :
Murphy, Sabina A.
Cannon, Christopher P.
Blazing, Michael A.
Giugliano, Robert P.
White, Jennifer A.
Lokhnygina, Yuliya
Reist, Craig
Im, KyungAh
Bohula, Erin A.
Isaza, Daniel
Lopez-Sendon, Jose
Dellborg, Mikael
Kher, Uma
Tershakovec, Andrew M.
Braunwald, Eugene
Pokaż więcej
Temat :
Cardiology and Cardiovascular Medicine
Źródło :
Journal of the American College of Cardiology. 67
Tytuł :
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Autorzy :
Cannon, Christopher P
Blazing, Michael A
Giugliano, Robert P
McCagg, Amy
White, Jennifer A
Theroux, Pierre
Darius, Harald
Lewis, Basil S
Ophuis, Ton Oude
Jukema, J Wouter
De Ferrari, Gaetano M
Ruzyllo, Witold
De Lucca, Paul
Im, KyungAh
Bohula, Erin A
Reist, Craig
Wiviott, Stephen D
Tershakovec, Andrew M
Musliner, Thomas A
Braunwald, Eugene
Califf, Robert M
Pokaż więcej
Temat :
Double-Blind Method
Acute Coronary Syndroms
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Acute Coronary Syndrome/drug therapy
Aged
Anticholesteremic Agents/adverse effects
Anticholesteremic Agents/therapeutic use
Azetidines/adverse effects
Azetidines/therapeutic use
Cardiovascular Diseases/epidemiology
Cardiovascular Diseases/mortality
Cardiovascular Diseases/prevention & control
Cholesterol, LDL/blood
Drug Therapy, Combination
Ezetimibe
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Kaplan-Meier Estimate
Male
Middle Aged
Simvastatin/therapeutic use
Triglycerides/blood
lipids (amino acids, peptides, and proteins)
Simvastatin
Cholesterol, LDL
Cardiovascular Diseases
Triglycerides
Statin Therapy
Azetidines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
acute coronary syndrome
aged
anticholesteremic agents
azetidines
cardiovascular diseases
cholesterol, ldl
double-blind method
drug therapy, combination
ezetimibe
female
humans
hydroxymethylglutaryl-coa reductase inhibitors
kaplan-meier estimate
male
middle aged
simvastatin
triglycerides
medicine (all
Anticholesteremic Agents
Acute Coronary Syndrome
[SDV]Life Sciences [q-bio]
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Źródło :
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (25), pp.2387-97. ⟨10.1056/NEJMoa1410489⟩
The New England journal of medicine, vol. 372, no. 25, pp. 2387-2397
Opis pliku :
STAMPA; application/pdf
Tytuł :
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Autorzy :
Cannon, Christopher P
Blazing, Michael A
Giugliano, Robert P
McCagg, Amy
White, Jennifer A
Theroux, Pierre
Darius, Harald
Lewis, Basil S
Ophuis, Ton Oude
Jukema, J Wouter
De Ferrari, Gaetano M
Ruzyllo, Witold
De Lucca, Paul
Im, KyungAh
Bohula, Erin A
Reist, Craig
Wiviott, Stephen D
Tershakovec, Andrew M
Musliner, Thomas A
Braunwald, Eugene
Califf, Robert M
Clemmensen, Peter Michael
Pokaż więcej
Temat :
Acute Coronary Syndrome
Aged
Anticholesteremic Agents
Azetidines
Cardiovascular Diseases
Cholesterol, LDL
Double-Blind Method
Drug Therapy, Combination
Ezetimibe
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Kaplan-Meier Estimate
Male
Middle Aged
Simvastatin
Triglycerides
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Źródło :
Cannon, C P, Blazing, M A, Giugliano, R P, McCagg, A, White, J A, Theroux, P, Darius, H, Lewis, B S, Ophuis, T O, Jukema, J W, De Ferrari, G M, Ruzyllo, W, De Lucca, P, Im, K, Bohula, E A, Reist, C, Wiviott, S D, Tershakovec, A M, Musliner, T A, Braunwald, E, Califf, R M, IMPROVE-IT Investigators & Clemmensen, P M 2015, ' Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes ', The New England Journal of Medicine, vol. 372, no. 25, pp. 2387-2397 . https://doi.org/10.1056/NEJMoa1410489
Tytuł :
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
Autorzy :
Blazing, Michael A.
Giugliano, Robert P.
Cannon, Christopher P.
Musliner, Thomas A.
Tershakovec, Andrew M.
White, Jennifer A.
Reist, Craig
McCagg, Amy
Braunwald, Eugene
Califf, Robert M.
Pokaż więcej
Temat :
Cardiology and Cardiovascular Medicine
Źródło :
American Heart Journal. 168
Tytuł :
Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Autorzy :
Schuyler Jones, W.
Baumgartner, Iris
Hiatt, William R.
Heizer, Gretchen
Conte, Michael S.
White, Christopher J.
Berger, Jeffrey S.
Held, Peter
Katona, Brian G.
Mahaffey, Kenneth W.
Norgren, Lars
Blomster, Juuso
Millegård, Marcus
Reist, Craig
Patel, Manesh R.
Fowkes, F. Gerry R.
Jones, W Schuyler
International Steering Committee and Investigators of the EUCLID Trial
Pokaż więcej
Źródło :
Circulation; 1/17/2017, Vol. 135 Issue 3, p241-250, 10p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies